Vertex Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$499.65(as of Jun 29, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Vertex Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$499.65
Ticker SymbolVRTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees6,400
CountyUSA
Market Cap$124,704.8M
EBIDTA4,981.2M
10-Day Moving Average469.58
P/E Ratio29.52
20-Day Moving Average454.53
Forward P/E Ratio25.77
50-Day Moving Average442.80
Earnings per Share16.85
200-Day Moving Average442.19
Profit Margin34.53%
RSI75.64
Shares Outstanding253.8M
ATR12.66
52-Week High507.92
Volume1,980,972
52-Week Low362.50
Book Value19,361.9M
P/B Ratio6.61
Upper Keltner483.02
P/S Ratio10.45
Lower Keltner426.05
Debt-to-Equity Ratio483.02
Next Earnings Date08/03/2026
Cash Surplus1,612.3M
Next Ex-Dividend DateUnknown
Vertex is a biotech leader that focuses on cutting-edge research and the development of transformative medicines for people with life-threatening diseases. The company has built a reputation for developing groundbreaking treatments that target the underlying cause of genetic diseases rather than just treating symptoms. Their flagship product, Trikafta, has shown remarkable results in treating cystic fibrosis.
Vertex Pharmaceuticals Inc In Our Stock Scanner
As of Jun 30, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.